Similar articles

• [Prophylaxis with gentamycin reduces bacterial infection morbidity and mortality caused by permanent tunneled central venous catheter].

  Fernández-Gallego J, Alonso A, Sujan S, Gutiérrez E. Fernández-Gallego J, et al. Nefrologia. 2007;27(2):228-9. Nefrologia. 2007. PMID: 17564574 Spanish. No abstract available.
• Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.

  Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA. Yücel N, et al. J Antimicrob Chemother. 2004 Dec;54(6):1109-15. doi: 10.1093/jac/dkh483. Epub 2004 Nov 10. J Antimicrob Chemother. 2004. PMID: 15537696 Clinical Trial.
• Risk factors for central venous catheter-related infections in general surgery.

  Chen HS, Wang FD, Lin M, Lin YC, Huang LJ, Liu CY. Chen HS, et al. J Microbiol Immunol Infect. 2006 Jun;39(3):231-6. J Microbiol Immunol Infect. 2006. PMID: 16783454
• Current issues in central venous catheter infection.

  Toltzis P, Goldmann DA. Toltzis P, et al. Annu Rev Med. 1990;41:169-76. doi: 10.1146/annurev.me.41.020190.001125. Annu Rev Med. 1990. PMID: 2184721 Review.
• Intravascular catheter-associated infections.

  Widmer AF. Widmer AF. Schweiz Med Wochenschr. 1997 Mar 15;127(11):444-56. Schweiz Med Wochenschr. 1997. PMID: 9098918 Review.